Filter
418
Text search:
vials
Featured
70
115
Language
Document type
202
96
37
34
18
10
9
9
2
1
Countries / Regions
52
13
12
11
9
9
8
8
8
7
6
6
6
5
5
5
5
4
4
4
4
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
157
75
26
23
19
14
11
Toolboxes
59
46
26
22
20
18
16
15
14
9
6
5
5
5
4
3
1
1
1
1
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Accessed December 2017
Since May 2019, Confirmation of 4 new emergence of type 2 vaccine-derived poliovirus (VDPV2) in Bambari (2) and Bimbo (2) health districts without any genetic link between them and other known viruses ; Bambari Health District: CAF-RS4-BAM-19-058, onset of paralysis: May 02, 2019. 07 positive contac
...
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the
...
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
Last revised 2015.
Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Determinants%20of%20damaged%20or%20poor%20quality%20supplies_SOP.doc
Practical hints are provided for mOPV1 storage and handling at the sub-district and health centre levels
Practical hints are provided for mOPV1 storage and handling at regional stores
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex
...
